The Crucial Role of Pharmacovigilance Databases in Ensuring Drug Safety
*Corresponding Author:Received Date: Feb 01, 2024 / Published Date: Feb 29, 2024
Warning: Undefined variable $i in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Warning: Undefined variable $for_cr in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Copyright: © 0 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Pharmacovigilance databases play a pivotal role in the proactive monitoring and assessment of drug safety. This article explores the essential functions of these databases in collecting, analyzing, and interpreting data related to adverse events associated with pharmaceutical products. The focus is on how Pharmacovigilance databases contribute to risk assessment, signal detection, regulatory compliance, and post-marketing surveillance. The challenges in maintaining data quality and completeness are discussed, along with advancements in data integration, interoperability, and the incorporation of artificial intelligence. As a critical component of pharmacovigilance, these databases are integral in ensuring the ongoing safety of drugs throughout their lifecycle